Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for OKUR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 176.39M
March 31, 2026 192.11M
December 31, 2025 59.05M
September 30, 2025 70.33M
June 30, 2025 83.37M
March 31, 2025 96.66M
December 31, 2024 110.76M
September 30, 2024 76.67M
June 30, 2024 76.67M
March 31, 2024 82.84M
December 31, 2023 29.88M
September 30, 2023 125.61M
Date Value
June 30, 2023 142.68M
March 31, 2023 93.79M
December 31, 2022 101.17M
September 30, 2022 116.08M
June 30, 2022 126.85M
March 31, 2022 138.66M
December 31, 2021 147.67M
September 30, 2021 157.73M
June 30, 2021 167.33M
March 31, 2021 91.22M
December 31, 2020 53.61M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 79.13M
Theriva Biologics, Inc. 11.34M
Nkarta, Inc. 182.76M
Unicycive Therapeutics, Inc. 61.42M
ACADIA Pharmaceuticals, Inc. 956.47M